Colon cancer patients with high expression of ERCC4 showed significantly favourable OS than those with low ERCC4 expression according to multivariate analysis in males (adjusted HR = 0.54, 95% CI = 0.30–0.96, P = 0.035). The gene discussed is ERCC4; the disease is malignant colon neoplasm.